Non-tuberculous Mycobacterial Infections Clinical Trial
Official title:
Efficacy and Tolerability of Linezolid for Treatment of Nontuberculous Mycobacterial Diseases
A prospective open study to determine the efficacy and tolerability of oral linezolid 600mg./day for the treatment of 40 patients with nontuberculous mycobacterial diseases will be conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.
This will be an open label clinical study of oral linezolid combination with another oral
antimycobacterial drug as the maintenance treatment of nontuberculous mycobacterial diseases
in adult.
The eligible patients will be treated and monitored for the efficacy and safety every 6 weeks
until 6 months then every 3 months for a total duration of 18 months.
;